Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Read more about Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study Read more about New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) Read more about A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder Read more about Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Read more about A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
A Research Study for Latina Women Undergoing Breast Cancer Treatment Read more about A Research Study for Latina Women Undergoing Breast Cancer Treatment
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome Read more about Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults Read more about Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
NeurostImulation for Cognitive Enhancement in Alzheimer's Disease Read more about NeurostImulation for Cognitive Enhancement in Alzheimer's Disease
A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) Read more about A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)